Treating Parkinson's disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson University researchers report in a new study published online November 28 in the Journal of the Neurological Sciences.
Read more at: http://medicalxpress.com/news/2012-11-drug-advance-parkinson-disease-symptoms.html#jCp
Read more at: http://medicalxpress.com/news/2012-11-drug-advance-parkinson-disease-symptoms.html#jCp
No comments:
Post a Comment